- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Nuclear receptor subfamily 5 group A member 2 (NR5A2), commonly known as Liver receptor homolog 1 (LRH1), is a ligand-regulated nuclear receptor involved in transcriptional control of cholesterol metabolism, bile acid signaling, glucose homeostasis, and epithelial developmental pathways. NR5A2 Antibody / Metabolic Signaling Transcription Factor Antibody recognizes a nuclear transcriptional regulator associated with metabolic adaptation and endocrine-associated gene expression networks.
NR5A2 antibody, also referred to as LRH1 antibody and Liver receptor homolog 1 antibody in the literature, is useful for investigation of nuclear receptor signaling pathways, epithelial differentiation programs, and metabolic transcriptional regulation. Polyclonal NR5A2 antibodies support studies examining endogenous nuclear receptor expression across multiple assay platforms including western blot, immunohistochemistry, and flow cytometry applications.
LRH1/NR5A2 is primarily localized to the nucleus where it regulates transcription of genes associated with steroidogenesis, lipid metabolism, bile acid synthesis, pancreatic function, and mitochondrial-associated metabolic pathways. Through interaction with transcriptional coactivators and promoter regulatory elements, NR5A2 contributes to maintenance of tissue-specific metabolic signaling states and epithelial cellular identity.
Expression of NR5A2 is enriched in liver, pancreas, intestine, and reproductive-associated tissues where metabolic signaling and endocrine-associated transcriptional regulation are highly active. In pancreatic and hepatic systems, LRH1-associated signaling contributes to cellular maintenance pathways and metabolic adaptation responses linked to nutrient regulation and biosynthetic activity.
In cancer biology research, dysregulated NR5A2 signaling has been associated with epithelial tumor progression, stemness-associated transcriptional regulation, and proliferative metabolic adaptation. Altered LRH1 expression has been investigated in pancreatic carcinoma, hepatocellular carcinoma, colorectal cancer, and additional epithelial malignancies characterized by metabolic signaling reprogramming.
Western blot analysis with NR5A2 antibodies commonly demonstrates nuclear receptor-associated bands near the expected molecular weight range of approximately 60-65 kDa, while immunohistochemistry and flow cytometry may demonstrate predominantly nuclear staining patterns consistent with transcription factor localization. Because NR5A2 participates in dynamic metabolic regulatory pathways, expression patterns may vary according to tissue type and physiologic state.
The broad biologic role of LRH1/NR5A2 in transcriptional regulation, metabolic signaling, and epithelial differentiation supports the utility of NR5A2 antibodies for investigating nuclear receptor-associated cellular pathways and metabolism-linked transcriptional networks.
Together, the available validation data support the use of NR5A2 antibody for investigating metabolic nuclear receptor signaling, epithelial transcriptional regulation, and LRH1-associated developmental biology.
For additional LRH1/NR5A2 research antibodies validated by HuProt specificity analysis, flow cytometry, and immunohistochemistry, explore the broader LRH1 Antibody page featuring clone PCRP-NR5A2-1B8.
Optimal dilution of the NR5A2 Antibody / Metabolic Signaling Transcription Factor Antibody should be determined by the researcher.
An E.coli-derived human recombinant protein (K192-A508) was used as the immunogen for the NR5A2 antibody.
After reconstitution, the NR5A2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
NR5A2 antibody, LRH1 antibody, Liver receptor homolog 1 antibody, orphan nuclear receptor antibody, metabolic nuclear receptor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.